This heartfelt moment beautifully illustrates CSL's values in action. Craig Kyngdon, a seasoned runner, helped colleague Phuong Dang tackle his first 10km run in over four years at the recent Run Melbourne event. Craig and Phoung personify the spirit of Collaboration that defines CSL. Their shared victory was a powerful reminder that with a little encouragement and belief, we can overcome any challenge, together. #CSL https://bit.ly/4dc7Pvm
About us
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra
- Website
-
https://www.csl.com/
External link for CSL
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Melbourne, Victoria
- Type
- Public Company
- Specialties
- Complex biologicals, vaccines, plasma and plasma derived therapeutics, and biotechnology
Locations
-
Primary
655 Elizabeth St
Melbourne, Victoria 3000, AU
-
1020 1st Ave
King of Prussia, PA 19406, US
Employees at CSL
Updates
-
DE&I isn’t just a conversation about the present, it’s a promise for the future. CSL is excited to be a presenting sponsor of the 2024 Triangle DEI Conference held in Raleigh, North Carolina. CSL representatives and members of our Holly Springs team connected with other field leaders to discuss the important role of sustainable, future-oriented DE&I practices in reinforcing CSL’s commitment to global health and patient care. Special thanks to Nidhi Chaudhary, MBA, SPHR, CPHR, CSL Global Head of Diversity, Equity & Inclusion, for sharing insights on the Business Case for DE&I in the Workplace. CSL is grateful to be a part of this ongoing conversation in the Research Triangle region of North Carolina and beyond! To learn more about our DE&I efforts, visit our website: https://bit.ly/3zYRYlN #CSL #DEICONF24 #DrivenByOurPromise #ResearchTriangle #DEI
-
CSL Behring is a global leader in biotherapies for rare and serious diseases. At CSL, we are dedicated to discovering, developing and delivering innovative treatments that improve patients’ lives. #CSL #CSLBehring Learn more: https://bit.ly/3YiVJMN
-
At CSL, we believe wholeheartedly in delivering Promising Futures for our people. What makes CSL such a unique organization and a great place to grow your career at any stage of life? Let’s hear from our Global R&D Senior Project Manager, Gamze Isitman. Feeling supported in her learning and growth, Gamze believes that she can give back to others in the hope that they can learn from her experiences. Here’s what she had to say. Learn more https://bit.ly/3WkKRvk #PromisingFutures #CSL #DoWhatThatMatters
-
On Sunday, a formidable force of 650 CSL employees took to the streets for Run Melbourne, an annual running event that underscores our commitment to the health and wellbeing of our employees. The sight of our sea of CSL red, the camaraderie of passing high-fives, and the enthusiastic cheers from our squad were truly inspiring. Congratulations to all our CSL participants— you made us incredibly proud! https://bit.ly/3xWjboE #CSL
-
It is 2009 and CSL begins human trials of the ‘swine flu’ influenza pandemic vaccine in Adelaide, South Australia. Our Parkville, Melbourne facility went on to manufacture millions of doses, helping Australia roll out one of the world’s first swine flu (H1N1) vaccination programs. CSL Seqirus is committed to pandemic preparedness and response and is a proud partner to over 30 governments worldwide. Learn more about how we continue to help governments prepare for future influenza pandemics: https://bit.ly/46c1PRh #CSL #CSLSeqirus #PublicHealth #Vaccines #InfluenzaPandemic
-
We’ll soon be trading hard hats and vests for clean room gowns! 👷👩🔬 We were delighted to show The Hon Ben Carroll MP, Deputy Premier of Victoria and Minister for Medical Research, around our shiny new state-of-the-art cell-based influenza vaccine and antivenom manufacturing facility in Tullamarine. The construction phase is ending and the qualification phase is set to begin on this landmark facility which will boost CSL Seqirus’ global manufacturing network and Australia’s sovereign capability for #vaccine production. #CSL #CSLSeqirus #DrivenByOurPromise #AustralianMade #AustralianManufacturing #PublicHealth #Influenza #Tullamarine
-
Together, we create breakthroughs. At CSL, collaboration is at the heart of everything we do. By working together across teams and disciplines, we bring innovative treatments to patients in need. www.csl.com #CSL #values
-
Meet Lena Rengifo, our Facility Coordination Officer at CSL Broadmeadow’s Facility F. Get a glimpse of her role in fractionation and how it’s pivotal in producing CSL’s therapeutic products. Discover the collaborative spirit and diversity that drive innovation at CSL. Lena’s journey reflects our commitment to making a global impact on people’s lives. Learn more https://bit.ly/4cI2rjZ #PromisingFutures #CSL #DoWhatThatMatters